July 19, 2024
Terasaki Institute for Biomedical Innovation Catalyzes Healthcare Revolution with Launch of Four Cutting-Edge Startups

image: 

In a landmark move for biomedical progress, the Terasaki Institute for Biomedical Innovation (TIBI) today unveiled the launch of four pioneering startup companies. By harnessing the institute’s groundbreaking research in biomaterials, micro-needles, organoids, tissue engineering, and advanced biosensing, these startups are poised to tackle some of the most pressing health challenges of our time.


view more 

Credit: Terasaki Institute for Biomedical Innovation

LOS ANGELES – (3/26/24) – In a landmark move for biomedical progress, the Terasaki Institute for Biomedical Innovation (TIBI) today unveiled the launch of four pioneering startup companies. These ventures represent a strategic leap forward in TIBI’s commitment to transforming healthcare through innovation. By harnessing the institute’s groundbreaking research in biomaterials, micro-needles, organoids, tissue engineering, and advanced biosensing, these startups are poised to tackle some of the most pressing health challenges of our time.

 

Introducing the Future of Biomedical Solutions:

  • BioOptix: Revolutionizing ocular health, BioOptix is at the forefront of creating smart contact lenses capable of delivering medications for severe eye conditions, including glaucoma. These lenses are equipped with state-of-the-art monitoring and sensing technology, enabling precise treatment modulation directly to the eye.
  • Digital Immunology: At the intersection of technology and immunology, Digital Immunology is pioneering the use of cutting-edge biomaterials, high-throughput digital culture platforms, organoid technology, and artificial intelligence. This innovative approach accelerates the development of targeted immunotherapies and vaccines to combat cancer and a spectrum of other diseases.
  • OnVagus: Introducing a breakthrough in neural health, OnVagus is developing a non-invasive, wearable patch that disrupts harmful vagus nerve signaling associated with cancer-induced weight loss and muscle atrophy. This signaling contributes to one-third of all cancer fatalities. The OnVagus patch offers a drug-free alternative that holds promise for treating not only cancer-related symptoms but also obesity, autoimmune disorders, and metabolic diseases.
  • Surgi-Zipper: Redefining surgical recovery, Surgi-Zipper’s innovative flexible patch provides a secure, leak-proof closure for air- or fluid-filled organs post-operation. Its unique biodegradable, double-layered design features a non-adhesive outer layer coupled with an inner layer that adheres to moist internal surfaces. The Surgi-Zipper is designed to remove tension from the surgical suture line in non-planar dynamic tissues and enhance healing, with potential applications extending to cardiovascular and pulmonary surgeries. The unique .chemical interactions between the adhesive layer and tissue allow ease of application and on-demand removal of the patch with laparoscopy or open surgery

 

Ali Khademhosseini, the esteemed Director and CEO of TIBI, expressed his enthusiasm: “The launch of these four startups marks a significant milestone in TIBI’s journey towards bringing our advanced biomedical research to the forefront of medical application. We are thrilled to see our vision of rapid innovation translation come to life, offering tangible solutions that will improve health outcomes and patient care.”

The Terasaki Institute for Biomedical Innovation remains dedicated to its mission of pioneering breakthroughs in biomedical science and technology. With the establishment of these startups, TIBI is not just envisioning the future of medicine—it is actively creating it.

###

About the Terasaki Institute for Biomedical Innovation

The Terasaki Institute for Biomedical Innovation is accelerating the pace of translational research by supporting the world’s leading scientists with an open, entrepreneurial environment for bioengineering new materials, biological models, and advanced technologies to address critical challenges to the health of the planet and its people. The Institute’s worldwide collaborations with academic, clinical, and entrepreneurial partners provide a rich foundation for translating innovations to the real world.

 

PRESS CONTACT

Stewart Han, [email protected], +1 818-836-4393

Terasaki Institute for Biomedical Innovation


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

link

Leave a Reply

Your email address will not be published. Required fields are marked *